Kenneth S Thomson

Title: Innovations by Kenneth S Thomson

Introduction

Kenneth S Thomson is a notable inventor based in Omaha, NE (US), recognized for his contributions to the field of microbiology and antibiotic susceptibility testing. With a total of 8 patents to his name, Thomson has made significant advancements that aid in the detection of antibiotic-inactivating enzymes.

Latest Patents

Thomson's latest patents include a device and direct method for the detection of antibiotic-inactivating enzymes. This method involves determining whether a microorganism produces an AmpC β-lactamase by admixing a culture of the microorganism with a β-lactam-containing antibiotic, a β-lactamase inhibitor resistant to AmpC β-lactamase, and a permeabilizing agent. The assay culture is maintained under appropriate conditions to ascertain the presence of the AmpC β-lactamase. Another significant patent focuses on a method for determining the antibiotic susceptibility of a microorganism. This involves admixing the microorganism culture with an antibiotic and a permeabilizing agent, followed by incubation to assess susceptibility.

Career Highlights

Throughout his career, Kenneth S Thomson has worked with various institutions, including Creighton University. His work has been pivotal in enhancing the understanding of antibiotic resistance and improving testing methods for microbial susceptibility.

Collaborations

Thomson has collaborated with notable colleagues such as Jennifer A Black and Ellen S Moland, contributing to the advancement of research in his field.

Conclusion

Kenneth S Thomson's innovative work in antibiotic detection and susceptibility testing has made a lasting impact on microbiology. His patents reflect a commitment to improving healthcare through scientific advancements.